查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1874002

心臟復健市场

Cardiac Rehabilitation Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

预计心臟復健市场将从 2024 年的 24.5 亿美元成长到 2031 年的 34 亿美元，2031 年至 2031 年的年复合成长率(CAGR) 为 6.7%。推动该市场成长的关键趋势包括心臟復健设备相关技术的进步。

心臟復健市场分析

预计未来十年，各公司推出的新产品将推动心臟復健服务需求的成长。例如，OmniVR 的「虚拟復健系统」提供可互动、可客製化的活动，支援坐姿和站姿两种復健姿势。该系统透过整合能够锻炼记忆力和执行功能的任务，帮助患者克服认知障碍。这种虚拟心臟復健方法能够提高患者的参与度和愉悦感，进而改善復健效果。

心臟復健市场概览

心臟復健计画能有效降低医院再入院率。 「心跳」（HeartBeat）就是一个例子，它是一项在社区内运作的综合性门诊心臟復健服务。復健课程由合格的医疗专业人员、咨商师和全科医生共同进行，他们会向计画组织者提供回馈，筛选合适的患者，鼓励患者参与，协助药物管理，并监测和治疗心血管疾病（CVD）风险因素。此类门诊计画对于应对未来几年心血管疾病发生率的上升至关重要。

战略洞察

心臟復健市场的驱动因素与机会

心血管疾病的增加有利于市场成长

根据美国心臟协会报告，心血管疾病（CVD）是美国首要死因，2020年造成928,741人死亡。因此，心血管疾病的日益增多凸显了心臟復健对于心臟病发作、心臟衰竭以及其他需要手术或药物治疗的心臟疾病患者的重要性。心血管疾病盛行率的不断上升是推动心臟復健服务需求成长的重要因素，从而提升了全球市场份额。

虚拟心臟復健的机会

居家或线上心臟復健（CR）计画能够有效消除患者获得传统中心式心臟復健服务的障碍，提供安全有效的服务。这些线上计画通常提供多种运动选择、每週简讯、心臟健康线上讨论、线上咨询以及包括冥想课程在内的专业工作坊。例如，凯撒医疗集团（Kaiser Permanente）于2024年6月启动了一项线上心臟復健项目，招募了超过2,300名患者，使其成为美国规模最大的计画之一。此计画使参与者在同一年因心臟相关疾病再次入院的比例低于2%。因此，从2021年到2031年，线上心臟復健市场蕴藏着巨大的成长潜力。

心臟復健市场細項分析

心臟復健市场分析按类型、病因、疾病类型、类别和最终用户进行细分。

  • 按产品划分，市场包括心率监测器、稳定球、跑步机、椭圆机、血压监测器、固定式自行车等，其中跑步机在 2023 年占据最大的市场份额。
  • 按应用领域划分，市场分为血管成形术、冠状动脉疾病、心肌病变、胆固醇管理、糖尿病和肺移植，其中血管成形术在 2023 年将成为领先细分市场。
  • 按最终用户划分，市场分为医院和诊所、专科医院、家庭医疗保健、心臟復健中心和其他，其中心臟復健中心在 2023 年占据了市场份额的主导地位。

心臟復健市场的地理分析

心臟復健市场的地理分析分为五个区域：北美、亚太地区、欧洲、中东和非洲、南美和中美洲。

北美市场占据主导地位，其中美国市场份额最大，这得益于其拥有顶尖的心臟復健服务提供者以及政府对虚拟復健计画的支持。预计亚太地区未来几年将实现最高的成长率。

心臟復健市场报告范围

心臟復健市场的最新发展

心臟復健市场评估是基于从一手和二手研究中收集的定性和定量资料，包括重要的企业出版物、协会资料和资料库。该市场的主要发展趋势包括：

  • Lupin Digital Health推出了全球首个针对心臟科医生的「数位疗法证书」。他们的「Lyfe」计画是印度首个经临床验证的远距心臟復健计划，已被证实能够改善心臟健康，并提高心血管疾病患者的生活品质。 （资料来源：Lupin公司网站，2024年1月）

心臟復健市场报告的覆盖范围和交付成果

这份题为《心臟復健市场规模及预测（2021-2031）》的报告对市场进行了全面分析，涵盖以下领域：

  • 全球、区域和国家层面所有关键细分市场的市场规模和预测。
  • 市场趋势和动态，包括驱动因素、限制因素和主要机会。
  • 详细的PEST/波特五力模型和SWOT分析。
  • 市场分析涵盖关键趋势、全球和区域框架、主要参与者、法规和最新发展。
  • 产业格局和竞争分析，包括市场集中度、热力图分析、主要参与者和最新发展。
  • 深入的公司概况。

目录

第一章：引言

第二章：心臟復健市场及主要结论

第三章：研究方法

  • 覆盖范围
  • 二手研究
  • 初步研究

第四章：全球心臟復健市场及市场概况

  • 概述
  • PEST分析
    • 北美和PEST分析
    • 欧洲和PEST分析
    • 亚太地区及PEST分析
    • 中东和非洲 (MEA) 及 PEST 分析
    • 南美洲和中美洲（SCAM）及PEST分析
  • 专家意见

第五章：心臟復健市场及主要市场动态

  • 市场驱动因素
    • 心血管疾病发生率上升
    • 远距心臟復健的普及应用日益广泛
  • 市场限制
    • 心臟復健设备成本高昂
  • 市场机会
    • 政府支持倡议
  • 未来趋势
    • 技术先进的心臟復健产品日益增多
  • 影响分析

第六章：心臟復健市场及全球分析

  • 全球心臟復健市场收入预测与分析
  • 全球心臟復健市场（依地域划分）－预测与分析
  • 关键参与者的市场定位

第七章：心臟復健市场分析及产品分类

  • 概述
  • 心臟復健市场收入份额（按产品划分）（2020 年和 2031 年）
  • 心率监测器
  • 稳定球
  • 跑步机
  • 划船者
  • 椭圆机
  • 血压监测仪
  • 固定式自行车
  • 其他的

第八章：心臟復健市场分析及应用

  • 概述
  • 按应用领域分類的心臟復健市场收入份额（2020 年和 2031 年）
  • 血管成形术
  • 冠状动脉疾病
  • 心肌病变
  • 胆固醇管理
  • 糖尿病
  • 肺移植

第九章：心臟復健市场及最终用户

  • 概述
  • 2020 年及 2031 年心臟復健市场（依配销通路划分）(%)
  • 医院和诊所
    • 概述
    • 医院及诊所：心臟復健市场及收入预测（至2031年）
  • 家庭医疗保健
    • 概述
    • 家庭医疗保健：心臟復健市场及收入预测（至2031年）
  • 专科医院
    • 概述
    • 专科医院：心臟復健市场及收入预测（至2031年）
  • 心臟復健中心
    • 概述
    • 心臟復健中心：心臟復健市场及收入预测（至2031年）
  • 其他的
    • 概述
    • 其他：心臟復健市场及收入预测（至2031年）

第十章：全球心臟復健市场及地理分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 亚太其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第十一章：新冠肺炎疫情对全球心臟復健市场的影响

  • 北美洲
  • 欧洲
  • 亚太
  • 中东和非洲
  • 南美洲和中美洲

第十二章：心臟復健市场及产业概况

  • 概述
  • 市场中各公司采取的成长策略（%）
  • 有机发展
    • 概述
  • 无机物发展
    • 概述

第十三章：公司简介

  • Halma plc
  • OMRON Corporation
  • AVECINNA
  • Koninklijke Philips N.V.
  • General Electric Company
  • Core Health and Fitness, LLC
  • Peloton Interactive, Inc.
  • Resideo Technologies, Inc
  • ergoline GmbH
  • HealthCare International
简介目录
Product Code: TIPHE100000851

The cardiac rehabilitation market is anticipated to grow from US$ 2.45 billion in 2024 to US$ 3.4 billion by 2031, reflecting a compound annual growth rate (CAGR) of 6.7% during the period from 2031 to 2031. Key trends driving this market include advancements in technology related to cardiac rehabilitation devices.

Analysis of the Cardiac Rehabilitation Market

New product introductions by companies are expected to boost the demand for cardiac rehabilitation services over the next decade. For instance, OmniVR's "Virtual Rehabilitation System" features interactive, customizable activities for both seated and standing positions. This system addresses cognitive impairments in patients by incorporating tasks that engage memory and executive functions. The virtual approach to cardiac rehabilitation enhances patient engagement and enjoyment, leading to improved functional outcomes.

Overview of the Cardiac Rehabilitation Market

Cardiac rehabilitation programs are effective in lowering hospital readmission rates. An example is "HeartBeat," a comprehensive outpatient cardiac rehabilitation service that operates within the community. Sessions are conducted by qualified health professionals, counselors, and general practitioners who provide feedback to program organizers, select appropriate patients, encourage attendance, assist with medication management, and monitor and treat cardiovascular disease (CVD) risk factors. Such outpatient programs are crucial in managing the increasing rates of cardiovascular diseases in the coming years.

Strategic Insights

Drivers and Opportunities in the Cardiac Rehabilitation Market

Increasing Cardiovascular Diseases Favoring Market Growth

As reported by the American Heart Association, cardiovascular disease (CVD) was the leading cause of death in the US, resulting in 928,741 fatalities in 2020. Consequently, the rise in cardiovascular diseases underscores the importance of cardiac rehabilitation for individuals recovering from heart attacks, heart failure, and other cardiac issues requiring surgical or medical intervention. This growing prevalence of cardiovascular diseases is a significant driver of demand for cardiac rehabilitation services, thereby enhancing the global market share.

Opportunities in Virtual Cardiac Rehabilitation

Home-based or virtual cardiac rehabilitation (CR) programs can effectively eliminate barriers to accessing traditional center-based CR, providing safe and beneficial services. These virtual programs typically offer exercise options, weekly newsletters, live discussions on heart health, virtual consultations, and specialized workshops, including meditation sessions. For example, Kaiser Permanente launched a virtual cardiac rehabilitation program in June 2024, enrolling over 2,300 patients, making it one of the largest programs in the US. This initiative resulted in cardiac-related hospital readmissions for participants being less than 2% in the same year. Thus, virtual cardiac rehabilitation presents a significant opportunity for market growth from 2021 to 2031.

Segmentation Analysis of the Cardiac Rehabilitation Market

The cardiac rehabilitation market analysis is segmented based on type, cause, disorder type, category, and end user.

  • By product, the market includes heart rate monitors, stabilization balls, treadmills, elliptical trainers, blood pressure monitors, stationary bicycles, and others, with the treadmill segment holding the largest market share in 2023.
  • By application, the market is divided into angioplasty, coronary artery disease, cardiomyopathy, cholesterol management, diabetes, and lung transplant, with angioplasty being the leading segment in 2023.
  • By end user, the market is categorized into hospitals & clinics, specialty hospitals, home healthcare, cardiac rehabilitation centers, and others, with cardiac rehabilitation centers dominating the market share in 2023.

Geographical Analysis of the Cardiac Rehabilitation Market

The geographic analysis of the Cardiac Rehabilitation market is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America leads the market, with the US holding the largest share due to the presence of top cardiac rehabilitation service providers and government support for virtual rehabilitation programs. The Asia Pacific region is expected to experience the highest growth rate in the coming years.

Scope of the Cardiac Rehabilitation Market Report

Recent Developments in the Cardiac Rehabilitation Market

The Cardiac Rehabilitation market is assessed through qualitative and quantitative data collected from primary and secondary research, including significant corporate publications, association data, and databases. Notable developments in the market include:

  • Lupin Digital Health has launched the world's first "Digital Therapeutics Certificate" for cardiologists. Their program "Lyfe" is India's first clinically validated remote cardiac rehabilitation initiative, proven to enhance heart health and improve the quality of life for cardiovascular patients. (Source: Lupin, Company Website, January 2024)

Coverage and Deliverables of the Cardiac Rehabilitation Market Report

The report titled "Cardiac Rehabilitation Market Size and Forecast (2021-2031)" provides a comprehensive analysis of the market, covering the following areas:

  • Market size and forecast at global, regional, and country levels for all key segments.
  • Market trends and dynamics, including drivers, restraints, and key opportunities.
  • Detailed PEST/Porter's Five Forces and SWOT analysis.
  • Market analysis covering key trends, global and regional frameworks, major players, regulations, and recent developments.
  • Industry landscape and competition analysis, including market concentration, heat map analysis, prominent players, and recent developments.
  • In-depth company profiles.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Cardiac Rehabilitation Market and By Product
    • 1.3.2 Global Cardiac Rehabilitation Market and By Application
    • 1.3.3 Global Cardiac Rehabilitation Market and By End User
    • 1.3.4 Global Cardiac Rehabilitation Market and By Geography

2. Cardiac Rehabilitation Market and Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Cardiac Rehabilitation Market and Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America and PEST Analysis
    • 4.2.2 Europe and PEST Analysis
    • 4.2.3 Asia Pacific and PEST Analysis
    • 4.2.4 Middle East and Africa (MEA) and PEST Analysis
    • 4.2.5 South and Central America (SCAM) and PEST Analysis
  • 4.3 Expert Opinions

5. Cardiac Rehabilitation Market and Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Incidences of Cardiovascular Diseases
    • 5.1.2 Growing Adoption of Tele-Cardiac Rehabilitation
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Cardiac Rehabilitation Equipment
  • 5.3 Market Opportunities
    • 5.3.1 Supportive Government Initiatives
  • 5.4 Future Trends
    • 5.4.1 Rise in Technologically Advanced Cardiac Rehabilitation Products
  • 5.5 Impact Analysis

6. Cardiac Rehabilitation Market and Global Analysis

  • 6.1 Global Cardiac Rehabilitation Market Revenue Forecast and Analysis
  • 6.2 Global Cardiac Rehabilitation Market, By Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Cardiac Rehabilitation Market Analysis and By Products

  • 7.1 Overview
  • 7.2 Cardiac Rehabilitation Market Revenue Share, by Products (2020 and 2031)
  • 7.3 Heart Rate Monitors
    • 7.3.1 Overview
    • 7.3.2 Heart Rate Monitors: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 7.4 Stabilization Balls
    • 7.4.1 Overview
    • 7.4.2 Stabilization Balls: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 7.5 Treadmill
    • 7.5.1 Overview
    • 7.5.2 Treadmill: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 7.6 Rower
    • 7.6.1 Overview
    • 7.6.2 Rower: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 7.7 Elliptical Trainer
    • 7.7.1 Overview
    • 7.7.2 Elliptical Trainer: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 7.8 Blood Pressure Monitor
    • 7.8.1 Overview
    • 7.8.2 Blood Pressure Monitor: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 7.9 Stationary Bicycle
    • 7.9.1 Overview
    • 7.9.2 Stationary Bicycle: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 7.10 Others
    • 7.10.1 Overview
    • 7.10.2 Others: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)

8. Cardiac Rehabilitation Market Analysis and By Application

  • 8.1 Overview
  • 8.2 Cardiac Rehabilitation Market Revenue Share, by Application (2020 and 2031)
  • 8.3 Angioplasty
    • 8.3.1 Overview
    • 8.3.2 Angioplasty: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 8.4 Coronary Artery Disease
    • 8.4.1 Overview
    • 8.4.2 Coronary Artery Disease: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 8.5 Cardiomyopathy
    • 8.5.1 Overview
    • 8.5.2 Cardiomyopathy: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 8.6 Cholesterol Management
    • 8.6.1 Overview
    • 8.6.2 Cholesterol Management: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 8.7 Diabetes
    • 8.7.1 Overview
    • 8.7.2 Diabetes: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 8.8 Lung Transplant
    • 8.8.1 Overview
    • 8.8.2 Lung Transplant: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)

9. Cardiac Rehabilitation Marketand By End User

  • 9.1 Overview
  • 9.2 Cardiac Rehabilitation Market, by Distribution Channel, 2020 and 2031 (%)
  • 9.3 Hospitals and Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Clinics: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 9.4 Home Healthcare
    • 9.4.1 Overview
    • 9.4.2 Home Healthcare: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 9.5 Specialty Hospitals
    • 9.5.1 Overview
    • 9.5.2 Specialty Hospitals: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 9.6 Cardiac Rehabilitation Centers
    • 9.6.1 Overview
    • 9.6.2 Cardiac Rehabilitation Centers: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)
  • 9.7 Others
    • 9.7.1 Overview
    • 9.7.2 Others: Cardiac Rehabilitation Marketand Revenue and Forecasts to 2031 (US$ Million)

10. Global Cardiac Rehabilitation Market and Geographical Analysis

  • 10.1 North America: Cardiac Rehabilitation Market
    • 10.1.1 Overview
    • 10.1.2 North America: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
    • 10.1.3 North America: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
    • 10.1.4 North America: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
    • 10.1.5 North America: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
    • 10.1.6 North America: Cardiac Rehabilitation Market, by Country, 2020 and 2031 (%)
      • 10.1.6.1 US: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.1.6.1.1 US: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.1.6.1.2 US: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.1.6.1.3 US: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.1.6.1.4 US: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.1.6.2 Canada: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.1.6.2.1 Canada: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.1.6.2.2 Canada: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.1.6.2.3 Canada: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.1.6.2.4 Canada: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.1.6.3 Mexico: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.1.6.3.1 Mexico: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.1.6.3.2 Mexico: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.1.6.3.3 Mexico: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.1.6.3.4 Mexico: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
  • 10.2 Europe: Cardiac Rehabilitation Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Cardiac Rehabilitation Market - Revenue and Forecasts to 2031 (USD Million)
    • 10.2.3 Europe: Cardiac Rehabilitation Market, by Device, 2024 and 2031 (USD Million)
    • 10.2.4 Europe: Cardiac Rehabilitation Market, by Application 2024 and 2031 (USD Million)
    • 10.2.5 Europe: Cardiac Rehabilitation Market, by End-User 2024 and 2031 (USD Million)
    • 10.2.6 Europe: Cardiac Rehabilitation Market, by Country, 2020 and 2031 (%)
      • 10.2.6.1 Germany: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.1.1 Germany: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.1.2 Germany: Cardiac rehabilitation Market, by Product 2024 and 2031 (USD Million)
        • 10.2.6.1.3 Germany: Cardiac rehabilitation Market, by Application 2024 and 2031 (USD Million)
        • 10.2.6.1.4 Germany: Cardiac rehabilitation Market, by End-User 2024 and 2031 (USD Million)
      • 10.2.6.2 UK: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.2.1 UK: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.2.2 UK: Cardiac Rehabilitation Market, Product, 2024 and 2031 (USD Million)
        • 10.2.6.2.3 UK: Cardiac Rehabilitation Market, by Application 2024 and 2031 (USD Million)
        • 10.2.6.2.4 UK: Cardiac Rehabilitation Market, by End-User 2024 and 2031 (USD Million)
      • 10.2.6.3 France: Cardiac rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.3.1 France: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.3.2 France: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.2.6.3.3 France: Cardiac Rehabilitation Market, by Application 2024 and 2031 (USD Million)
        • 10.2.6.3.4 France: Cardiac Rehabilitation Market, by End-User 2024 and 2031 (USD Million)
      • 10.2.6.4 Italy: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.4.1 Italy: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.4.2 Italy: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.2.6.4.3 Italy: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.2.6.4.4 Italy: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.2.6.5 Spain: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.5.1 Spain: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.5.2 Spain: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.2.6.5.3 Spain: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.2.6.5.4 Spain: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.2.6.6 Rest of Europe: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.6.1 Rest of Europe: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.2.6.6.2 Rest of Europe: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.2.6.6.3 Rest of Europe: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.2.6.6.4 Rest of Europe: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
  • 10.3 Asia Pacific: Cardiac Rehabilitation Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Cardiac Rehabilitation Market - Revenue and Forecasts to 2031 (USD Million)
    • 10.3.3 Asia Pacific: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
    • 10.3.4 Asia Pacific: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
    • 10.3.5 Asia Pacific: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
    • 10.3.6 Asia Pacific: Cardiac Rehabilitation Market, by Country, 2020 and 2031 (%)
      • 10.3.6.1 Japan: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.1.1 Japan: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.1.2 Japan: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.3.6.1.3 Japan: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.3.6.1.4 Japan: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.3.6.2 China: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.2.1 China: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.2.2 China: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.3.6.2.3 China: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.3.6.2.4 China: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.3.6.3 India: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.3.1 India: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.3.2 India: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.3.6.3.3 India: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.3.6.3.4 India: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.3.6.4 South Korea: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.4.1 South Korea: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.4.2 South Korea: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.3.6.4.3 South Korea: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.3.6.4.4 South Korea: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.3.6.5 Australia: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.5.1 Australia: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.5.2 Australia: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.3.6.5.3 Australia: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.3.6.5.4 Australia: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.3.6.6 Rest of Asia Pacific: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.6.1 Rest of Asia Pacific: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.3.6.6.2 Rest of Asia Pacific: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.3.6.6.3 Rest of Asia Pacific: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
  • 10.4 Middle East and Africa: Cardiac Rehabilitation Market
    • 10.4.1 Overview
    • 10.4.2 Middle East and Africa: Cardiac Rehabilitation Market - Revenue and Forecasts to 2031 (USD Million)
    • 10.4.3 Middle East and Africa: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
    • 10.4.4 Middle East and Africa: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
    • 10.4.5 Middle East and Africa: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
    • 10.4.6 Middle East and Africa: Cardiac Rehabilitation Market, by Country, 2020 and 2031 (%)
      • 10.4.6.1 Saudi Arabia: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.4.6.1.1 Saudi Arabia: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.4.6.1.2 Saudi Arabia: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.4.6.1.3 Saudi Arabia: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.4.6.1.4 Saudi Arabia: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.4.6.2 UAE: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.4.6.2.1 UAE: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.4.6.2.2 UAE: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.4.6.2.3 UAE: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.4.6.2.4 UAE: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.4.6.3 South Africa: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.4.6.3.1 South Africa: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.4.6.3.2 South Africa: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.4.6.3.3 South Africa: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.4.6.3.4 South Africa: Cardiac Rehabilitation Market, by End User, 2024 and 2031 (USD Million)
      • 10.4.6.4 Rest of Middle East and Africa: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.4.6.4.1 Rest of Middle East and Africa: Cardiac Rehabilitation Market and Revenue and Forecasts to 2031 (USD Million)
        • 10.4.6.4.2 Rest of Middle East and Africa: Cardiac Rehabilitation Market, by Product, 2024 and 2031 (USD Million)
        • 10.4.6.4.3 Rest of Middle East and Africa: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
        • 10.4.6.4.4 Rest of Middle East and Africa: Cardiac Rehabilitation Market, by Application, 2024 and 2031 (USD Million)
  • 10.5 South and Central America: Cardiac Rehabilitation Market
    • 10.5.1 Overview
    • 10.5.2 South and Central America: Cardiac Rehabilitation Market - Revenue and Forecasts to 2031 (USD Million)
    • 10.5.3 South and Central America: Cardiac Rehabilitation Market, by Product, 2019 -2031 (USD Million)
    • 10.5.4 South and Central America: Cardiac Rehabilitation Market, by Application, 2019 -2031 (USD Million)
    • 10.5.5 South and Central America: Cardiac Rehabilitation Market, by End User, 2019 -2031 (USD Million)
    • 10.5.6 South and Central America: Cardiac Rehabilitation Market Share by Country and 2020 and 2031, (%)
      • 10.5.6.1 Brazil: Cardiac Rehabilitation Market- Revenue and Forecasts to 2031 (USD Million)
        • 10.5.6.1.1 Brazil: Cardiac Rehabilitation Market- Revenue and Forecasts to 2031 (USD Million)
        • 10.5.6.1.2 Brazil: Cardiac Rehabilitation Market, by Product, 2019 -2031 (USD Million)
        • 10.5.6.1.3 Brazil: Cardiac Rehabilitation Market, by Application, 2019-2031 (USD Million)
        • 10.5.6.1.4 Brazil: Cardiac Rehabilitation Market, by End User, 2019-2031 (USD Million)
      • 10.5.6.2 Argentina: Cardiac Rehabilitation Market- Revenue and Forecasts to 2031 (USD Million)
        • 10.5.6.2.1 Argentina: Cardiac Rehabilitation Market- Revenue and Forecasts to 2031 (USD Million)
        • 10.5.6.2.2 Argentina: Cardiac Rehabilitation Market, by Product, 2019 -2031 (USD Million)
        • 10.5.6.2.3 Argentina: Cardiac Rehabilitation Market, by Application, 2019 -2031 (USD Million)
        • 10.5.6.2.4 Argentina: Cardiac Rehabilitation Market, by End User, 2019 -2031 (USD Million)
      • 10.5.6.3 Rest of South and Central America: Cardiac Rehabilitation Market- Revenue and Forecasts to 2031 (USD Million)
        • 10.5.6.3.1 Rest of South and Central America: Cardiac Rehabilitation Market- Revenue and Forecasts to 2031 (USD Million)
        • 10.5.6.3.2 Rest of South and Central America: Cardiac Rehabilitation Market, by Product, 2019 -2031 (USD Million)
        • 10.5.6.3.3 Rest of South and Central America: Cardiac Rehabilitation Market, by Application, 2019-2031 (USD Million)
        • 10.5.6.3.4 Rest of South and Central America: Cardiac Rehabilitation Market, by End User, 2018-2027 (USD Million)

11. Impact Of COVID-19 Pandemic on Global Cardiac Rehabilitation Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
  • 11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Cardiac Rehabilitation MarketandIndustry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in the Market, (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Halma plc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 OMRON Corporation
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 AVECINNA
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Koninklijke Philips N.V.
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 General Electric Company
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Core Health and Fitness, LLC
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Peloton Interactive, Inc.
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Resideo Technologies, Inc
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 ergoline GmbH
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 HealthCare International
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments